Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs in Australia 2009

This report considers the population benefits, value and cost-effectiveness of needle and syringe programs.

Page last updated: 2009

Back to:

This report was conducted by a team of investigators at the National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia. The technical analysis was carried out by David Wilson, Amy Kwon, Jonathan Anderson, and Rosie Thein. Matthew Law, Lisa Maher, Greg Dore, James Ward, and John Kaldor acted in an advisory manner. Jenny Iversen, Heather Gidding, Rachel Deacon, Bethany White, and Melanie Middleton provided and interpreted data for use in the analysis.

For further information, contact Associate Professor David Wilson:
  • Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, AUSTRALIA
  • Telephone: 02 9385 0900
  • Facsimile: 02 9385 0920
  • Email: